Search Results 2211-2220 of 16239 for Epilepsy (Partial Onset)

1. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

   Participation eligibility · Diagnosis of secondary or atypical parkinsonism. · Onset of any parkinsonian motor sign or symptom > 5 years before Screening Visit.

2. A Study to Assess Virtual Reality As Anesthesia Adjunct During Electrophysiology Lab Procedures - Mayo Clinic

   Current diagnosis of epilepsy, dementia, or other neurological disease that may prevent use of VR hardware and software; Sensitivity to flashing light or ...

3. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study. If the patient is postmenopausal or has documented ...

4. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

   ... duration of study participation; men treated or enrolled on this protocol ... duration of study participation, and 4 months after completion of MLN8237 ...

5. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The primary objective of this study is to evaluate the safety and effectiveness of inhaled treprostinil in subjects with Idiopathic Pulmonary Fibrosis (IPF).

6. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells - Mayo Clinic

   Seizures or history of significant neurological injury;; Multi-system organ failure including acute or chronic renal failure. Participating Mayo Clinic ...

7. Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis - Mayo Clinic

   The purpose of this study is to test the hypothesis that benralizumab will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in ...

8. A Study to Map White Matter Cognitive Functions Using Stereo EEG - Mayo Clinic

   Undergoing stereo EEG for localization of epilepsy will be recruited. English speaking. Exclusion Criteria: Patients under the age of 18. Non-English ...

9. Itchy Skin Clinical Trials - Mayo Clinic Research

   Subjects on GSK2330672 will also receive placebo tablets to maintain blinding. The total duration of a subject's participation will be up to 45 days of ...

10. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

    The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of shortening the duration and ...